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  The increase in antibacterial resistance has placed the issue of microbial multi-drug 
resistance on a global stage (Gurunathan, 2019). This issue poses a threat to human and animal 
health as well as to the environment (Aslam et al., 2018). It affects not only the efficacy of 
treatment but also how those treatments are conducted (Friedman, Temkin, & Carmeli, 2016). As 
a result of this ongoing threat, new treatments that have potent effects on bacteria are necessary. 
One scientific response to this issue has been the development of multifunctional nanoparticles 
(NPs)(H. Wang et al., 2018). NPs have the ability to be utilized by its varying modes of action and 
compatibility with other forms of treatments (Alavi & Rai, 2019). This advantage, when 
successful, would allow for the lowering of dosage and frequency of treatments required to achieve 
bacteria killing (Alavi & Rai, 2019).  
Despite a plethora of proposed designs for the improvement of antibacterial treatment, 
questions remain concerning the mode of action of these new agents.  The aim of this study is to 
develop a protocol facilitating the identification of modes of action of newly formulated 
antibacterial agents. Our hypothesis is that different modes of action will have distinct effects on 
the morphology and composition of the cells. To test this, we characterized the structural, physical 
and molecular changes of a model system, E. coli., before and after treatments using antibiotics 
with known modes of action. We selected two bactericidal antibiotics: colistin which is a 
membrane disrupting antibiotic, and streptomycin which is a protein inhibiting antibiotic (Santo-
Domingo, Chareyron, Broenimann, Lassueur, & Wiederkehr, 2017; Sun et al., 2019; 
Thummeepak, Kitti, Kunthalert, & Sitthisak, 2016). We discuss the protocol development and the 
significant differences observed in the bacterial responses as well as the limitations of the 
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envisioned approach. We conclude by providing a perspective of the impact our findings are 
expected to have on evaluating new engineers NP treatments. 
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CHAPTER ONE: INTRODUCTION 
1.1 Introduction and Aim 
Antibacterial resistance has emerged as a serious and far reaching issue (Aslam et al., 2018; 
Fair & Tor, 2014; Friedman et al., 2016; Ibrahim, Mattar, Abdel-Khalek, & Azzam, 2017; 
Rehm & Weber, 2007)with implications far beyond the immediate issues of morbidity and 
mortality (Doi et al., 2017).  In addition to the impacts already experienced in hospitals and 
medicine, the significant reliance on antibiotics in agriculture is expected to lead to new threats 
related to food production in the near future. In agriculture, antibiotics are used for treating 
diseases of plants and animals, including for handling simple infection or for more serious 
cases such as post-operative care (Chang, Wang, Regev-Yochay, Lipsitch, & Hanage, 2015; 
McManus, Stockwell, Sundin, & Jones, 2002). Alongside the natural adaptation of bacteria, 
the mis-use and misdoing of antibiotic treatments have accelerated the need for new solutions 
to overcome bacterial resistance (Rashid et al., 2019; Shallcross & Davies, 2014). Each 
antibiotic is developed with a specific mode of action, which defines the manner in which it 
will inhibit bacteria. Typical targets of the mode of action of antibiotics include: cell wall 
synthesis, translational machinery and DNA replication (L. L. Wang, Hu, & Shao, 2017). Once 
a bacterial strain develops tolerance or resistance to a given mode of action, increasing the dose 
or frequency of the treatment is not a sustainable solution. This can be seen with the current 
accumulation of Copper (Cu) in soil resulting from increasing the treatment concentration and 
frequency in fields in an effort to manage developing diseases. In addition to showing little 
improvement in managing diseases, such accumulation often brings about new issues such as 
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leaching in surrounding waters and affecting the microbiomes of interconnected ecosystems. 
Treatments with new modes of actions must be developed as alternative solutions to these 
emerging threats. However, the development, assessment and registration of such antibacterial 
formulation is tedious and lengthy. 
As a solution to this problem scientists have been increasingly considering the use of 
nanoparticles (NPs) to tailor drug with high efficacy and faster response times (Alavi & Rai, 
2019; Baptista et al., 2018b; Gurunathan, 2019; H. Wang et al., 2018). Recent studies have 
revealed a potential for high efficacy of nanoparticles in treating bacteria when used as carriers 
for drug delivery. The most attractive aspect of using NPs for drug delivery is their ability to 
load a range of antibacterial cargos for delivery to the targeted systems (Baptista et al., 2018a). 
NPs such as gold (Au), silver (Ag) copper (Cu) and zinc oxide (ZnO) have been highlighted 
for either potential in fighting drug resistance (Hemeg, 2017). However, many of the modes of 
action of nanoparticles and nanomaterials remain unknown.   
Based on the impact of antibacterial resistance and the importance of antibiotic treatments 
to medicine and agriculture, the overarching goals of the present study aims to develop suitable 
characterization schemes that could later be used to evaluate the impact of engineered NPs on 
bacteria-although this validation in out of the scope of the present study. In particular, we aim 
to evaluate the impact of the treatment on the morphology and chemical signatures of bacteria, 
to determine whether some (or all) could eventually be used as markers to monitor antibacterial 
treatments and their modes of action on bacteria. To achieve this, we used a bacterial model, 
Escherichia coli (E. Coli), treated with antibiotics with defined mode of action - namely 
colistin and streptomycin. Physical and chemical responses of the cells such as chemical 
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composition, length, width and surface roughness to the antibacterial treatments were recorded 
and analyzed.   
By establishing this benchmark, we expect to better understand structural and molecular 
changes experienced by the same bacterial model system within the future. 
 
1.2 Bacteria and their Structure 
Bacteria are living single-cell organisms with dimensions in the range of 1-5 m. They are 
prokaryotes, which means that they do not have a nucleus. They are found in a broad range of 
environments from water, soils, food or human bodies. Classification of these bacteria is usually 
done based on the properties of the cell walls, their shapes (round, rod-like, helicoidal, etc) and 
sometimes their genetic makeup. For instance, bacteria can be classified as “gram-positive” and 
“gram-negative”, which  corresponds to their ability to retain the crystal violet dye during the 
procedure of gram-staining (Blount, 2015).  
   
Figure 1. E. coli structure (left) and cell wall composition (right). E. coli is composed of a cell body and a 
flagellum. A cell envelope surrounds the cytoplasm. The cell wall which is composed of the inner membrane, the 
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periplasm and the outer membrane. The inner membrane consists of a symmetric lipid bilayer composed of 
phospholipids and membrane proteins. The periplasm contains the peptidoglycan cell wall. The outer membrane is 
an asymmetric lipid bilayer encompassing a layer of phospholipids on the side of the periplasm and 
lipopolysaccharide (LPS) on the outermost layer. The outer membrane also contains proteins but with different 
secondary conformations. The inner and outer membranes are both anchored in the periplasm with lipoproteins.  
 
Escherichia coli (E. coli) is common model system for gram-negative bacteria. It is an 
essential organism that has been used to unveil many biological findings, such as cracking the 
genetic code by revealing information about DNA transcription, translation and replication 
(Blount, 2015).  
As a gram-negative cellular system, E. Coli’s structure consists of two membranes each 
made up of lipopolysaccharides that regulate the entry of substances into and out of the cell (Figure 
1). Between these two membranes exists a thin peptidoglycan layer that allows for the cell to 
maintain its rigid structure (Blount, 2015; Silhavy, Kahne, & Walker, 2010). The outermost layer 
of the cell is composed of lipopolysaccharides (LPS) that are made up of polysaccharides and 
lipids (Jann & Jann, 1987; Stahle & Widmalm, 2019). LPS act as a permeability barrier to cationic 
antimicrobial peptides, which helps intracellular survival (Delcour, 2009; Stahle & Widmalm, 
2019). LPS and polysaccharides also maintain the integrity of the cell structure. LPS is the primary 
layer involved in the interaction of the bacterium with surfaces (Reyes, Suárez, Sierra, & Beswick, 
2009). It has been shown that he host-pathogen interaction and the host immune evasion system 
can be controlled by the polysaccharide (Aduse-Opoku et al., 2006).  
Figure 1 (right panel) also shows that the outer membrane contains porins and 
transmembrane proteins. Porins control the permeability of cell by governing the optimal nutrient 
access across the membrane (Liu & Ferenci, 1998). They consist of channels that control the 
diffusion of hydrophilic molecules between the environment and the periplasm. The 
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transmembrane proteins of the outer membrane contain beta folds that are usually arranged in an 
antiparallel conformation. These have been ascribed, in part, to help E. coli withstand harsh 
environments (Rollauer, Sooreshjani, Noinaj, & Buchanan, 2015). The periplasmic space 
separates the outer membrane from the inner membrane and contains a gel like fluid (Miller & 
Salama, 2018). The inner membrane encloses the cytoplasm and serves as a dynamic substructure 
(Papanastasiou et al., 2013). The phospholipids provide a pathway for substances to move across 
membranes (Barak & Muchova, 2013). Overall, the complexity and heterogeneous composition 
of the bacterial cell wall is still a topic of ongoing research, in which even minor lipids are found 
to play essential roles in cellular activities (De Kruijff, Killian, Rietveld, & Kusters, 1997; Luirink, 
Yu, Wagner, & de Gier, 2012). Both the outer and inner structures together adapt to optimize 
bacterial survival in variable and stress conditions (Rowlett et al., 2017). In particular, alterations 
in membrane phospholipids have been shown to impair bacterial cellular structure and function, 
as well as their mechanisms of adaptation to stress, including their ability of form biofilms (Rowlett 
et al., 2017).  
 
1.3 Conventional antibiotics and their modes of action 
1.3.1 Background 
Antibiotics can be classified based on the cellular system they affect. The classification is 
also dependent on whether the antibiotic can induce cell death (bactericidal) or inhibit cell growth 
(bacteriostatic) (Kohanski, Dwyer, & Collins, 2010).  Common modes of action include inhibition 
of cell wall synthesis (e.g. penicillin), inhibition of cell membrane function (e.g. colistin), 
inhibition of protein synthesis (e.g. tetracycline, streptomycin), inhibition of nucleic acid synthesis 
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(e.g. metronidazole) and inhibition of other metabolic processes such as the folic acid pathway 
(Kohanski et al., 2010). Here we focus on comparing the effect of two modes of action of 
bactericidal antibiotics: inhibition of cell membrane function –using colistin– and inhibition of 
protein synthesis –using streptomycin. 
1.3.2 Inhibition of cell membrane function with Colistin 
Colistin, also known as polymyxin E, is a bactericidal antibiotic often used as a last resort 
to treat Gram-negative bacteria, such as multidrug-resistant (MDR) gram-negative bacteria (Vaara, 
2019). As MDR bacteria develop resistance against colistin treatments, some infections may be 
left with no cure (Hinchliffe et al., 2017). However, reports of colistin resistance have been quite 
rare. The few instances of prevalence of colistin-resistant bacteria (E. coli) that have been recently 
reported include a study in Vietnam (Yamamoto et al., 2019) and a study on specific strains such 
as Acinetobacter baumannii (Qureshi et al., 2015). We note that due to the ever-changing survival 
mechanisms of bacteria such as chromosomal mutation, resistance is expected to rise (Hinchliffe 
et al., 2017).  
The interaction of colistin and a lipid membrane representative of gram-negative bacteria 
has been investigated by various methods, including by Circular Dichroism (CD) spectroscopy 
(Dupuy et al., 2018). The study revealed no significant differences in secondary structural changes 
in the lipid membrane mimics, which ruled out protein conformational change as the cause of its 
bactericidal activity (Dupuy et al., 2018). However, in membranes corresponding to gram-negative 
bacteria, colistin slightly increased the stiffness and chain order, suggesting that it could displace 
divalent cations leading to membrane perturbation (Dupuy et al., 2018). Colistin also interacted 
with the lipopolysaccharide of the membrane of gram-negative bacteria with high affinity, which  
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was interpreted as a mechanism for the antibiotic to dock to the cell surface (Dupuy et al., 2018). 
The final and most lethal action of colistin is the damage it causes to the cytoplasmic membrane 
(Vaara, 2019). These studies indicate that colistin has a more primary effect on the outer membrane 
of the bacteria cell although the activity can have several consequences on the living system. These 
findings discussed in the literature provide support for the scenario of membrane disruption as a 
mode of action for this antibiotic treatment (Dupuy et al., 2018; Vaara, 2019). These studies 
constitute the basis for our selection of colistin a model to study the effect of membrane disruption 
in E. Coli. 
 
1.3.3 Inhibition of protein synthesis with Streptomycin 
Streptomycin is another bactericidal antibiotic drug. It is commonly used to treat both 
gram-positive and gram-negative bacteria in humans especially for tuberculosis (Grayson et al., 
2017), animals (Nicoletti, Lenk, Popescu, & Swenson, 1989) and plants such as for fire blight in 
apple and pear trees (Aćimović, Zeng, McGhee, Sundin, & Wise, 2015). The primary mode of 
action for streptomycin is the inhibition of protein synthesis by binding within the 30s ribosomal 
subunit (Iscla, Wray, Wei, Posner, & Blount, 2014). This irreversible binding leads to bacterial 
death via misreading of the mRNA template (Luzzatto, Apirion, & Schlessinger, 1968). The 
difference in mode of action of streptomycin compared with colistin provides an interesting 




1.4 Hypothesis of the work 
In this work, we formulated the hypothesis that two modes of action such as inhibiting 
membrane function and inhibiting protein synthesis will have different effects on the morphology 
and chemical changes of antibacterial-sensitive bacterial systems such as E. Coli. To test this 
hypothesis, we established an experimental protocol encompassing evaluation of the morphology 





CHAPTER TWO: CHARACTERIZATION TOOLS  
2.1 Introduction 
We evaluated the dimensions and shape of the bacteria, their surface roughness, and 
chemical composition. The characterization tools used for this study were selected by taking into 
account the scale of the features to resolve and the properties of the sample. Bacteria are soft 
flexible structure with dimensions below 5 m in length and 1 m in width. Although 
measurements are carried out in dry conditions, to resolve changes in cell membrane roughness 
one has to consider a tool capable of imaging sub-micrometer structures without the need to stain 
the sample. Atomic Force Microscopy (AFM) was identified as a well-suited tool as it provides 
nanoscale resolution of biological systems in their native environments. Similarly, to study the 
composition of the bacteria and the changes occurring as a result of antibacterial treatments, we 
elected to use Fourier Transform Infrared Spectroscopy (FTIR), which provides insight on the 
behavior of the cell culture as an ensemble, and Raman confocal spectroscopy, which allows to 
focus the excitation light onto a few bacteria at a time for a better understanding of the 
heterogeneities of the cell responses within the ensemble.  
2.2 Instrumentation – Principle of the techniques 
2.2.1 Atomic Force Microscopy   
AFM uses a cantilever with a sharp metal tip (probe) to scan over the surface of the sample.  
The tip-sample interactions lead to cantilever deflection, which can be monitored using a read-out 
laser to reconstruct the topography of the sample surface  (Cheng et al., 2019).  Over the years, 
AFM has been exploited to reveal the sample’s molecular interaction, surface hydrophobicity, 
surface charges and its other mechanical properties (Dufrene, 2014). Previous studies have used 
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AFM to determine the Young’s modulus of cells and its evolution upon treatments of bacterial 
cells (Mathelie-Guinlet et al., 2018).  In addition to this, AFM can probe the rigidity of the cell, its 
height and longitudinal area when exposed to multiple antibiotic treatments (Li et al., 2016). 
One common mode of AFM imaging is contact mode. In our study, contact mode with a 
gentle applied load and a soft cantilever were used to image the bacteria. In contact mode, the 
forces between the tip and the sample are predominantly repulsive due to the short tip-sample 
distance. The system is setup to monitor changes in cantilever deflection as the cantilever rasters 
the sample. The changes in deflection are monitored with the read-out laser (Figure 2) reflected 
off the top layer of the cantilever and directed to a position sensitive detector (or photodiode). The 
recorded signals (in Volts) are then converted into a Height image (in nm). 
 
Figure 2. AFM principle. The AFM setup encompasses a cantilever, laser source, photodiode detector, and 
controller. An AFM image is created by engaging the cantilever tip with the surface of the sample. In contact mode, 
engaging the tip corresponds to reducing the tip-sample distance to enter the repulsive force regime. Once engaged, 
the tip is scanned across the region of interest. The deflection of the cantilever is monitored using a read-out laser 
reflected off the back of the cantilever to a position sensitive detector. The voltage of the detector is recorded in 
Volts and converted into a Height image.  
2.2.2 Raman Spectroscopy 
 Raman Spectroscopy uses inelastically scattered light resulting from light (usually in the 
visible range)-matter interaction to reveal information about the molecular vibrations, and thus the 
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composition, of a sample (Chisanga, Muhamadali, Ellis, & Goodacre, 2019). The proportion of 
inelastically scattered photons resulting from the interaction of visible excitation light with the 
sample is extremely small (approximately one in 10 million). Thus, sufficient laser power and 
integration time (time during which the CCD detector collects scattered photons) should be 
selected to detect the signal from the sample. The excitation light in focused on the sample using 
an objective (from 20x to 100x magnification). The same objective is used to collect the scattered 
photons. Inelastic scattering results from excitation of the electrons in the sample from ground 
state to a virtual state. For inelastic decay, some of the energy is exchanged with molecules and 
excites vibrational modes of the chemical bonds. This energy “loss” corresponds to the information 
studied to determine the composition of the sample probed. The setup of Raman spectroscopy is 
depicted in Figure 3. 
Raman spectroscopy has been used to discriminate strains of E. coli and other bacteria 
types.  Peak intensities and positions are commonly used to identify changes in a sample. Data 
analysis schemes aiming to identify minute changes between bacterial strains have been 
developed, including multivariate analysis (Germond et al., 2018; Sapers et al., 2019). The 
literature indicates that Raman spectroscopy is capable of distinguishing changes in evolving 
bacterial system (Martin & Pollock, 2010; Ren, Ji, Teng, & Zhang, 2017), suggesting that it should 




Figure 3. Raman Spectroscopy Setup including the excitation laser (532nm), the objective for focusing and 
collecting light, the notch filter to block elastically scattered light and the spectrometer to analyze the Raman signal. 
The data is collected by a CCD detector in the spectrometer.  
 
2.2.3 Fourier Transform Infrared Spectroscopy  
 FTIR also uses light-matter interaction to determine the chemistry of the sample. In this 
case, the excitation is in the infrared range. The sample absorbs infrared energy that corresponds 
to vibrational states of the chemical bonds in the material (Figure 4(a)).  The spectra obtained can 
be analyzed  to determine the molecular composition and potentially the secondary structure of the 
sample (Gallastegui et al., 2019). FTIR has been used to assess how E. coli and other gram-
negative bacteria change when exposed to external stress (Corte et al., 2015). In a similar manner 
as Raman spectroscopy, the position and intensity of the IR bands representing the functional 
groups are used to determine the compositional changes in a sample (Gupta & Karthikeyan, 2016).   
To characterize a sample in liquid, such as with bacteria, an attenuated total reflection (ATR) 
configuration is commonly used. In ATR, the light passes through an IR transparent crystal 
designed to create total internal reflection (Figure 4(b)). In the spectrometer used in this study, a 
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diamond layer was deposited on top of a ZnSe prism for protection. The incoming light is oriented 
at an angle greater than the critical angle, resulting in the creation of evanescent waves that 
illuminate the sample above the surface of the crystal with a depth of about 0.5-5 μm  (Blum & 
John, 2012). The energies absorbed to excite molecular vibrations do not get reflected, and result 
in a “missing” band in the signal recorded by the detector. 
  (a)  
(b)  
Figure 4. FTIR Spectroscopy (a) and ATR configuration (b). FTIR spectroscopy consists in using mid-infrared 
light to illuminate a sample and studying the absorbed energies by monitoring the signal with an IR detector. The 
setup includes a Michelson interferometer as a mean to introduce an intensity modulation and interference pattern 
that can be used to obtain the full IR spectrum in the 400-4000cm-1 range in a short collection time. The ATR 
configuration allows for liquid measurement was using the concept of evanescent waves to probe the sample at the 
interface of the ATR crystal. The total internal reflected wave contains the information of the sample.  
 
For both Raman and FTIR spectroscopy, selection rules have been formulated to determine 
whether an energy transition corresponding to a bond vibration is active or inactive. For this 
reason, Raman and FTIR spectroscopy provide complementary information about the sample.  
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Together, these three methods of characterization are expected to provide a holistic view 
of how the treatments are affecting the bacteria to possibly identify markers specific to each 







CHAPTER THREE: EXPERIMENTAL METHODS 
3.1 Bacteria Growth 
Culture and treatment of E. coli were performed in collaboration with Dr. Santra’s group. 
The growth broth, incubation time for growth and the strain of E. coli were kept constant.  One 
method for the growth of E. coli consists of inoculating a single colony of E. coli in 10 mL of Luria 
Bertani (LB) growth broth. The preparation was left overnight at 36˚C on a 150 rpm  shaking table 
(Maniprasad & Santra, 2012). Bacteria were studied in late log-phase or otherwise known as the 
late exponential phase.  Microbial growth in a culture sample or batch culture is usually modelled 
using four different phases: the lag, lag, stationary and death phase. The exponential phase cells 
growth is doubled, the growth rate is dependent on growth conditions such as nutrient 
concentration and aeration (Prado Barragán, Figueroa, Rodríguez Durán, Aguilar González, & 
Hennigs, 2016).  
3.2 Bacteria Treatment 
Antibiotics were obtained from Sigma Aldrich.  Before evaluating the effects of the 
treatments on the bacteria, the concentration and duration of the treatments had to be determined. 
To address this, in collaboration with Dr. Santra’s team, we carried out Minimum Inhibitory 
Concentration (MIC) assays.  
3.2.1 Minimum Inhibitory Concentration 
The Minimum Inhibitory Concentration (MIC) assay determines in vitro the concentration 
necessary to significantly inhibit cell multiplication. This is usually done on a standardized 
medium for 18 to 20 h from 34 to 37 °C. The MIC is an endpoint measurement and represents the 
bacteriostatic response (Mouton et al., 2017). In this study, E. coli were treated in a 1:1 ratio with 
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antibiotic. The MIC concentration ranges for  colistin and streptomycin on E. coli were initially 
estimated from the literature:  colistin: >2 µg/ml, and streptomycin: 16 µg/ml (Iscla et al., 2014; 
Sunde & Norstrom, 2005). 
3.2.2 Bacterial Treatment 
Once MIC were confirmed (colistin: 2.5 µg/ml, and streptomycin: 16 µg/ml) and E. coli 
culture were grown, several steps were taken to combine the treatments with the bacteria and 
prepare the sample for imaging.  
For the control, a total of 1 ml of E. coli was used. For all other cases, the bacteria and 
treatment were combined in a 1:1 ratio. After the treatment was added to the bacterial medium, the 
cultures were incubated for varying time periods depending on the types of antibacterial being 
used. A time study was performed for each antibiotic treatment. It was determined for colistin that 
a 2-hour incubation period was optimal and a 4-hour incubation period for streptomycin at the 
MIC was distinguishable from the control. 
 
3.2.3 Sample preparation for imaging and spectroscopy 
To prepare the E. coli solutions for infrared spectroscopy and nanoscale imaging, a washing 
protocol was enacted. This included centrifuging the solution of E. coli for 5 minutes at 4000 
relative centrifugal force, each time draining off the supernatant and adding approximately 1 ml 
of double deionized water before resuspending the water and bacteria. The process was repeated 
three times (Young, 2019). This washing protocol was validated for preliminary studies. Following 
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washing, the bacteria were pipetted onto a substrate that is compatible with the measurements 
(such as IR transparent substrate for infrared measurements) and allowed to dry in air.  
3.3 Instrumental Setup 
3.3.1 AFM Measurements 
Silicon was used as the substrate since it offers a flat surface which prevents topographic 
interference. Contact mode was used to acquire the height and deflection images of the sample 
surface. A scan rate of 0.5-1.0 Hz was used to acquire images of 512 points x 512 points for a 
region of 50 x 50 microns. A low force cantilever was used to prevent any damage to the bacteria. 
Data analysis was performed with Gwyddion, ImageJ and Origin. The length and width 
measurements were acquired using ImageJ; a total of 450 measurements were taken per sample.  
The surface roughness measurement were taken using Gwyddion by acquiring the arithmetic mean 
height Sa values for 180 measurements per sample.  
 
3.3.2 Raman Spectroscopy Measurements 
 At the start of the project, we evaluated several substrates for this measurement (Figure 5). 
We found that glass slides exhibit a signature interfering with the bacterial fingerprint. Hence, an 
IR transparent substrate (Zinc Sulfide) was used to prevent interferences in the Raman spectral 
range for E. coli.  
A 532 nm laser was used as excitation source in the Raman confocal system (WITec 300 
Alpha RA). Imaging was performed using a 100x objective. A region approximately 15x15 µm2 
populated with E. coli cells was probed. The laser power ranged from 1.30 to 1.33 mW to ensure 
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a good signal but to also prevent bacteria from burning. The 600 g/mm spectral grating was 
selected. Inelastically scattered photons were collected by a CCD detector using an integration 
time of 5 seconds (Germond et al., 2018). The spectra produced were corrected by cosmic rays 
removal and background subtraction. Further analysis was performed using WITec Project, 
Unscrambler, Origin and Fityk.  
 
Figure 5. Raman Spectra of Substrates with Untreated E. coli samples (a) Untreated E. coli on calcium fluoride 
substrate, (b) Untreated treated E. Coli on gold coated glass substrate (c) E. coli on silicon substrate.  
 
3.3.3 FTIR Measurements   
IR spectra were collected on a FTIR spectrometer (Perkin Elmer Spectrum One) covering 
the 4000-400 𝑐𝑚−1 range and set to a resolution of 4 𝑐𝑚−1.  
The FTIR was prepped by cleaning the crystal with isopropyl alcohol and Kim wipes. The 
background of each sample was acquired by placing a few drops of water on the crystal and 
acquiring the spectra. The sample spectra were then acquired. A total of 150 scan were acquired 
for each sample and replicated three times with different drops of the solutions (Gupta & 




3.3.4 Statistical analysis 
Analysis of variance (ANOVA) is frequently used statistical method of analysis. The focus 
of ANOVA is the differences in group variances. This method asses the relative size of variances 
among group means compared to the average variances with groups (Kim, 2014). ANOVA was 
used in this study to determine the statistical significance of the results between treated and 
untreated cells.  
 For infrared spectroscopy data, we deepened our analysis of the datasets with multivariate 
analysis, which entails the statistical study of data where multiple measurements are made on each 
experimental unit (Olkin & Sampson, 2001). It is based on the multidimensional observation and 
analysis of multiple statistical outcome variable being analyzed at one time (Mengual-Macenlle, 
Marcos, Golpe, & Gonzalez-Rivas, 2015). 
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CHAPTER FOUR: EXPERIMENTAL RESULTS  
The physical and chemical changes occurring in E. Coli due to various treatments were 
investigated by nanoscale imaging and infrared spectroscopy, respectively.  The physical changes 
were assessed by comparing the morphology of the cells before and after treatment. The chemical 
changes were studied by comparing Raman and IR bands of the bacteria fingerprint.  
 
4.1 Morphology and roughness of the bacteria evaluated by AFM 
 The changes in length and width, as well as the surface roughness of E. Coli were 
analyzed using AFM (Figure 6) to create a profile for the physical characteristics of the bacteria 
both prior and post treatment.  
 
Figure 6. AFM Images of untreated and treated E. coli. (a) Untreated E. coli 50x50 μm and 5x5 μm images, (b) 
Colistin treated E. coli 50x50 μm and 5x5 μm images with 2-hour incubation period, and (c) Streptomycin treated E. 






Figure 7. Histograms of length measurement from AFM scans for untreated and treated E. coli. (a) Frequency 
of length associated with untreated E. coli, (b) Frequency of length associated with colistin treated E. coli with 2 
hours incubation period and (c) Frequency of length associated with streptomycin treated E. coli with 4 hours 
incubation period. 
 
Table 1. Summary of changes in the mean length of untreated and treated E. coli.  
Treatment Mean Length (μm) Difference in mean (μm) 
Untreated  2.20 ± 0.49 --------- 
Colistin 2.06 ± 0.41 0.14 
Streptomycin  2.01 ± 0.47 0.19 
 
Length analysis was carried out from the AFM images collected. The histogram plots 
(Figure 7) make it possible to determine changes in length of the bacteria as a result of the antibiotic 
treatment. For the 450 bacteria that were analyzed, the untreated E. coli exhibited an average length 
of 2.20 μm. This is in line with the known length property of E. coli, which is generally 1 to 2 μm 
in length (El-Hajj & Newman, 2015). The measurements were extracted from 3 technical 
replicates.   
Following both the colistin and the streptomycin treatments, a slight reduction in length 
could be observed, around 0.14 μm for colistin (corresponding to a 6% decrease) and 0.19 μm for 
streptomycin (corresponding to an 8% decrease) (Table 1). This demonstrates that treatments 




Figure 8. Histogram of width measurements from AFM scans for untreated and treated E. coli. (a) Frequency 
of width associated with untreated E. coli, (b) Frequency of width associated with colistin treated E. coli with 2 
hours incubation period and (c) Frequency of width associated with streptomycin treated E. coli with 4 hours 
incubation period. 
 
Table 2. Summary of changes in the mean width of untreated and treated E. coli.  
Treatment Mean Width (μm) Difference in mean (μm) 
Untreated 1.18 ± 0.14 ------ 
Colistin 1.15 ± 1.15 0.03 
Streptomycin 1.10 ± 0.21 0.08 
 
 
Similar analysis was performed on the width of E. coli (Figure 8). An average width of 
about 1.18 μm was found the untreated cells. This is on the larger end of the spectrum of   reported 
width of E. coli, which usually range between 0.5 to 1 μm (Nanninga, 1988). AFM is known to 
provide some artifact in lateral measurements on samples such as bacteria, which could explain 
the slightly high value. Nonetheless, we could use AFM to compare the width between untreated 
and treated bacteria. With decreases of   0.08 μm for E. Coli following the streptomycin treatment 
and of 0.03 μm for E. Coli following the colistin treatment, which represents a 2-6% variation, it 
is difficult to confirm the impact of the treatment on the width of the cells (Table 2). 
  Nonetheless we note that overall streptomycin, the protein inhibiting treatment, seems to 





Figure 9. Histogram of surface roughness from AFM scans for untreated and treated E. coli. (a) Frequency of 
surface roughness associated with untreated E. coli, (b) Frequency of surface roughness associated with colistin 
treated E. coli with 2 hours incubation period and (c) Frequency of surface roughness associated with streptomycin 
treated E. coli with 4 hours incubation period. 
 
Table 3. Summary of changes in the mean width of untreated and treated E. coli.  
Treatment Mean Roughness (nm) Difference in mean 
(nm) 
Untreated 85.53 ± 25.39 ------ 
Colistin 43.96 ± 22.26 41.57 
Streptomycin  40.43 ± 16.39 45.10 
 
 Given that AFM offers finer details due to its spatial resolution beyond 100 nm, we 
investigated the surface roughness of the cells. Bacterial surface roughness is known to play a 
major role in their attachment and removal ability (H. Wang, Feng, Liang, Luo, & Malyarchuk, 
2009). The histograms in Figure 9 show the evolution of surface roughness because of antibiotic 
treatments. A total of 180 measurements were taken per sample treatment using the Gwyddion 
software. A mask was added to the region in evaluation and the statistical properties of the masked 
region were analyzed using the software. The surface roughness measurements were taken using 
the arithmetic mean height values, Sa. As summarized in Table 3, the untreated E. coli had an 
average surface roughness of 85.53 nm. Streptomycin led to the greatest reduction in surface 
roughness with a decrease of 45.10 nm from that of the untreated (~53% decrease). Colistin also 
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showed a significant decrease in surface roughness, of about 41.57 nm (~48%). This could be an 
indication that with treatment the bacteria are less capable of attachment due to its reduction in 
surface roughness.  
 The study of the physical traits of E. Coli suggests that both mode of actions affect the 
size and surface roughness of the cells, although streptomycin, the protein inhibiting treatment, 
seems to have a slightly higher effect (Figure 10). It showed a greater reduction in both width, 
length and surface roughness measurements. Next we detail our evaluation of the data using 




Figure 10. Box Plots of length, width and surface roughness distributions for untreated and treated E. coli. 
For all samples the box represents the 25th to 75th percentile, whiskers indicate the standard deviation and the middle 
square shows the mean. (a) Length distribution of treated and untreated E. coli, (b) Width distribution of treated and 
untreated E. coli (c) Surface roughness distribution of treated and untreated E. coli. 
 
Table 4. Statistical significance of p-tests with treated and untreated samples for (a) length, (b) width, and (c) 









































































































Sig.* = Significance 
 
  In biology, natural variations are responsible for changes in properties within a large 
ensemble of the same sample group. For instance, here, within the group on untreated bacteria, a 
range of length, width and surface areas could be observed (Figures 6-10 and Tables 1-4). To 
determine whether the behavior of one sample group is significantly different from that of a second 
sample group, statistical models have been implemented, such as ANOVA – developed by R. 
Fisher (Fisher, 1919). One-way ANOVA with the combination of the post hoc Tukey test (Tukey’s 
Honestly Significant Difference (HSD)) was conducted on the samples. Conducting a post hoc 
Tukey test with one-way ANOVA can test the differences among sample means for significance. 
The post hoc Tukey test has a better probability of controlling Type I errors; this is an incorrect 
rejection of true of the null hypothesis ("Encyclopedia of Research Design," 2010; Kim, 2015). 
Table 4 serves as an identifier for the statistical significance of each physical quantity of E. coli 
between each treatment and the untreated sample groups and between colistin treated and 
streptomycin treated groups. The differences between untreated and treated samples were found 
to be statistically significant at all three p-test, 0.05, 0,01 and 0.001. However, no statistical 
significance was found between the sample groups treated with colistin and streptomycin. Thus, 
length alone cannot be used as a physical marker of the mode of action. 
 Differences in width between treated and untreated groups were significant at all levels, 
however the width values to differentiate the two modes of actions were not statistically significant 
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according to p-tests 0.01 and 0.001. We note that significance existed at p-test 0.05.   Thus width 
measurements alone cannot be used as a reliable physical marker of the mode of action. Surface 
roughness of E. coli resulting from antibiotics treatments were also statistically significant when 
compared to the untreated sample group, but not when comparing the two treated groups.  Thus 
surface roughness measurements alone cannot be used as a reliable physical marker of the mode 
of action. 
Due to the lack in specificity of this measurements to differentiate the control groups, we 
investigated the chemical signatures of the bacteria.   
4.2 Composition of the bacteria investigated by infrared spectroscopy 
The Raman and IR spectra were collected as described in Chapter 3.  Interpretation of the 
spectra is discussed here, first on the as-collected spectra and later refined using peak 
deconvolution.  
4.2.1. Raman and IR signatures of E. Coli 
4.2.1.1 Raman Spectra of E. Coli 
Raman spectra of the untreated E. Coli (Figure 11) were analyzed by studying previous reports in 
the literature (Harz, Rösch, & Popp, 2009; Rösch et al., 2005; Wei, Li, & Zhao, 2018).  Water 
signal in Raman spectroscopy is generally not an issue do to the band above 3200 cm-1, which 
does not overlap with the fingerprint of bacteria in the 1000-1700 cm-1 and the region with strong 
hydrocarbon groups (CH, CH2, CH3)  in the 2800-3000 cm
-1 range. The fingerprint of untreated 
bacteria revealed several bands previously reported in the literature, the strongest one being at 
~2935 cm-1, which corresponds to a C-H stretching. The features are in good agreement with a 
27 
 
report by Harz et al. (Harz et al., 2009), which also used a 532 nm laser excitation to study 
bacterial cells Staphylo-coccus epidermidis ATCC 35984. In their study, the Raman signature of 
important building blocks of the bacteria were presented, and showed that DNA, 
polysaccharides, lipids and proteins all exhibit a strong signal in the 2800-3000 cm-1 region. The 
peak with maximum position at ~2935 cm-1 seems to be best aligned with the signal of proteins, 
while other side bands observed in our data at 2971 cm-1 and 2885 cm-1 would correspond to 
DNA and polysaccharides and/or lipids, respectively. Proteins were found to have several bands 
related to amide vibrations, including amide I (~1668 cm-1) and amide III (1253 cm-1) (Harz et 
al., 2009). The amide II band was not directly observed in our spectra. A small bands at ~ 1570 




Figure 11. Raman spectra of untreated E. coli. (a)Untreated bacteria for spectral range of 1000-3500 cm-1 and (b) 
Untreated bacteria for spectral range of 1000-1700 cm-1. 
  
Table 5. Summary of the Raman modes detected for untreated E. coli.   
Wavenumber (cm-1) Bond vibration Reference 
1013 Out of phase C-C-O 
stretch 
(Talari, Movasaghi, 




1107 C-O-C in carbohydrates  
C-C-O out of phase 
(Wei et al., 2018) 
1239 Amide III, lipids (Germond et al., 2018) 
1314 CH deformation (Talari et al., 2015) 
1458 CH2 scissoring (Talari et al., 2015) 
1556 Amide II (Talari et al., 2015) 
1668 Amide I (Talari et al., 2015) 
2886 CH2 stretch (Talari et al., 2015) 
2930 CH2  asymetic strecth (Talari et al., 2015) 
2971 asymmetric Stretching of 
Methoxy(4) 
(Talari et al., 2015) 




After treatments with the antibiotics (Figure 12), the bacteria exhibited some changes in 
fingerprint. Small changes in the bands at ~ 1013 cm-1 and ~1556 cm-1 were observed after the 
treatments suggesting a change in E. coli’s composition. 
 
 
Figure 12. Raman spectra of untreated and treated E. coli. (a) Untreated and treated bacteria with no incubation 
with formulation of treatment for spectral range of 1000-3500 cm-1 and (b) Untreated and treated bacteria with 
formulation of treatment for spectral range of 1000-1700 cm-1 
 
Table 6. Bands of untreated and treated E. coli. From Raman spectra for both the 1000-1700 cm-1 and 1000-3500 
















Functional group  Reference 
1107 X X C-O-C in 
carbohydrates 
C-C-O out of phase 
(Talari et al., 2015) 
1239 X X Amide III (Germond et al., 
2018; Talari et al., 
2015) 
1314 X 1330 1330; Phospholipids (Germond et al., 
2018; Talari et al., 
2015) 
1458 1454 1454 CH2 deformation (Germond et al., 
2018; Talari et al., 
2015) 
1556 Absent Absent Amide II (Germond et al., 
2018; Talari et al., 
2015) 
1668 1656 X 1656; Amide I (Talari et al., 2015) 
 
   CH2 defomation, potentially associated with phospholipid and collagen (Talari et al., 
2015), were identified based on the shift of the 1458 cm-1 band. The amide I compound was still 
present after the colistin treatment however, the wavenumber shifted from 1668 cm-1 to 1656 cm-
1. 
 Streptomycin had a similar spectral change to colistin, as the bands at ~1013 and 1556 
cm-1 (amide II) were both affected. Similar shift of the CH2 defomation was observed. The main 
difference was the shift of the 1314 cm-1  to 1330 cm-1 , indicative of a change in phospholipids. 
Phospholipids play serveral roles in bacteria, one major role being to establish the permeability 




4.2.1.2 IR Spectra of E. coli 
 IR spectra are complementary to Raman spectra. In our study the two methods did not 
probe the same volume. FTIR measurements correspond probing several bacteria whereas 
Raman probes one cell at a time. 
 
 
Figure 13. FTIR spectra of untreated and treated E. coli. (a)Untreated bacteria with no incubation with 
formulation of treatment for spectral range of 1000-1700 cm-1 and (b) Untreated and treated bacteria with 
formulation of treatment for spectral range of 1000-1750 cm-1 
 
Table 7. Summary of the IR modes detected for untreated E. coli.   
Wavenumber (cm-1) Functional group 
1052 P=O 
1223 C-O str 
1333 NO or CO 
1422 CH2 deformation 
1471 CH2 bending of lipid 
1576 Amide II 
1631 Amide I or II 




The spectrum (Figure 13(a)) reveals the IR active compounds of untreated E. coli. There appears 
to be signals from varous bonds, including P=O (Movasaghi, Rehman, & ur Rehman, 2008), as 
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well as bands related to lysaccharides and amides, similar to Raman spectra. Bacterial 
polysaccharides are usually associated with bacterial cell wall and membrane and amide stutures 
help classify the state of proteins of the bacteria (Misra, Sharma, & Srivastava, 2015). Additonal 
stutures such as the C=N and CH2 bending of lipids were present. The C-H stretching vibration 
can sometimes be used to gain information on the state of the freedom of motion and fatty acyl 
order (Guler, Gartner, Ziegler, & Mantele, 2016). A summary of the bands is provided in Table 
8. 
 














1052 1043 1054 P=O 
1223 1282 1218 Amide III 
1333 Absent Absent --- 
1422 Absent Absent --- 
1471 1448 1469 
CH3 bending of 
proteins 
1576 1549 1548 Amide II 
1631 Absent Absent --- 
1653 X 1641 Amide I 
 
Next we compared the reference spectrum of the untreated bacteria (Figure 13) to the 
fingerprint recorded for the treated samples (Figure 13(b)). In presence of the protein inhibiting 
treatments amide I shifted from an alpha helix structure at 1653-1657 cm-1 to a lower 
wavenumber amide I structure at 1641 cm-1(Movasaghi et al., 2008). In presence of colistin, the 
cell wall degrading treatment, the amide I band region did not change. However, a significant 
shift of the band at1222 cm-1 was observed in the case of colistin treatment, with a shift to 1282 




4.2.2. Peak deconvolution 
To refine our study of the different bands, we also experimented with spectral peak 
deconvolution.  This approach allows the decomposing of broad peaks into several sub-bands 
that overlap, which can provide information about otherwise hidden peaks. Fityk peak 
deconvolution software was used to deconvolute all spectra. We note here that peak 
deconvolution is a complex process that can provide varying outcomes, thus the analysis 
presented here should not be considered as final. 
Overall, this step revealed that the antibiotic treatments with different modes of action 




Figure 14. Raman peak deconvolution for untreated and treated E. coli. (a)Untreated bacteria with no 
incubation with formulation of treatment, (b) Colistin treated bacteria with 2 hours incubation period formulation of 
treatment, and (c) Streptomycin treated bacteria with 4 hours incubation period formulation of treatment. 
Table 9. Summary of the Raman Peak Deconvolution. (a) Relative Raman shift of comparison of compound in 
untreated with those of treatment, (b) Potential Raman shift of bands (not present in untreated) that occur due to 2 
hours incubated colistin treatment, and (c) Potential Raman shift of bands (not present in untreated) that occur due to 




Compound Untreated Colistin Streptomycin References 
Amide I 1668 1697 1670 (Talari et al., 2015) 
Tyrosine 1615 -- 1548 (Talari et al., 2015) 
Cytosine 1510 -- -- (Talari et al., 2015) 
Fatty Acid 1440 -- 1233 (Talari et al., 2015) 
C=C 1417 -- -- (Talari et al., 2015) 
Tryptophan 1365 1546 1548 (Talari et al., 2015) 
Amide III 1258 1224 -- (Talari et al., 2015) 
Carbohydrate 1153 -- 1063 (Talari et al., 2015) 
Phospholipid 1078 -- -- (Talari et al., 2015) 
 
(b) 
Compound Colistin References 
Amide I 1663, 1640 (Talari et al., 2015) 
Guanine 1570 (Talari et al., 2015) 
Deoxyribose 1455 (Talari et al., 2015) 
C-H Rocking 1389 (Talari et al., 2015) 
Amide III 1318 (Talari et al., 2015) 
Lipid 1255 (Talari et al., 2015) 
Amide I 1172 (Talari et al., 2015) 
C-C 1100 (Talari et al., 2015) 
Glucose 1071 (Talari et al., 2015) 
Phenylalanine of Collagen 1030 (Talari et al., 2015) 




Compound Streptomycin References 
Amide I 1647 (Talari et al., 2015) 
Phenylalanine 1582 (Talari et al., 2015) 
Deoxyribose 1457 (Talari et al., 2015) 
Guanine 1323 (Talari et al., 2015) 
Fatty Acid 1233 (Talari et al., 2015) 
Lipid 1095 (Talari et al., 2015) 
C-C 1063 (Talari et al., 2015) 
 
 
Our tentative deconvolution revealed various shifts specific each treatment (Figure 14). In 
addition, several peaks that were not present in the untreated sample seemed to appear after 
treatment (Table 9). This suggests that Raman spectroscopy when paired with peak deconvolution 
can serve as a method to distinguish the chemical signature associated with treatments that 






Figure 15. FTIR peak deconvolution for untreated and treated E. coli. (a)Untreated bacteria with no incubation 
with formulation of treatment, (b) Colistin treated bacteria with 2 hours incubation period formulation of treatment, 
and (c) Streptomycin treated bacteria with 4 hours incubation period formulation of treatment. 
 
Table 10. Wavenumber shift for FTIR peak deconvolution. (a) FTIR wavenumber comparison of compound in 
untreated with those of treatment, (b) Potential assignment of FTIR bands (not present in untreated) that occur due to 
2 hours incubated colistin treatment, and (c) Potential assignment of FTIR bands (not present in untreated) that 
occur due to 4 hours incubated streptomycin treatment. 
(a) 
Compound Untreated Colistin Streptomycin References  
Amide I 1652 1652 1634 (Movasaghi et 
al., 2008) 
Nucleic Acid 1619 -- -- (Movasaghi et 
al., 2008) 
Amide II 1536 
 





Phospholipid 1469 -- -- (Movasaghi et 
al., 2008) 
Collagen 1364 -- -- (Movasaghi et 
al., 2008) 
C-N Thymine 1328 -- -- (Movasaghi et 
al., 2008) 
N-H Thymine 1290 -- -- (Movasaghi et 
al., 2008) 
Amide III 1230 -- 1282 (Movasaghi et 
al., 2008) 
Polysaccharide 1162 -- 1125 (Movasaghi et 
al., 2008) 
RNA 1117 1117 -- (Movasaghi et 
al., 2008) 




Carbohydrate 1053 -- -- (Movasaghi et 
al., 2008) 




Compound Colistin References 
C=O 1712 (Movasaghi et al., 
2008) 
Amide II 1517 (Movasaghi et al., 
2008) 
Lipids 1444 (Movasaghi et al., 
2008) 
Deformation C-H, N-H 1416 (Movasaghi et al., 
2008) 
Deformation C-H, N-H 1355 (Movasaghi et al., 
2008) 
Polysaccharide 1334 (Movasaghi et al., 
2008) 
N-H Thymine 1288 (Movasaghi et al., 
2008) 
Collagen 1224 (Movasaghi et al., 
2008) 
Deoxyribose 1118 (Movasaghi et al., 
2008) 




Compound Streptomycin References 
C=N Adenine 1574 (Movasaghi et al., 2008) 
Amide II 1517 (Movasaghi et al., 2008) 
Polysaccharide 1434 (Movasaghi et al., 2008) 
Deformation 
C-H, N-H 
1412 (Movasaghi et al., 2008) 
Deformation 
 C-H, N-H 
1360 (Movasaghi et al., 2008) 
Amide III 1319 (Movasaghi et al., 2008) 
Phosphate I 1235 (Movasaghi et al., 2008) 
Phosphate I 1212 (Movasaghi et al., 2008) 
CH2 1183 (Movasaghi et al., 2008) 
Polysaccharide 1110 (Movasaghi et al., 2008) 
Deoxyribose 1056 (Movasaghi et al., 2008) 
Polysaccharide 1018 (Movasaghi et al., 2008) 
 The FTIR peak deconvolution of treated and untreated E. coli confirmed that the 
chemistry of the bacteria changed (Figure 15). The amide I, II and III bands present in the 
untreated sample shifted   in the treated samples indicating changes in the membranes (Table 10).  
When the treated samples were compared, the deformation of C-H and N-H are present in both 
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samples although they were not the same in untreated sample. It is also essential to note that 
several polysaccharide bands absent in the untreated were found in the streptomycin treated 
bacteria.  
 Both the peak deconvolution conducted from Raman and FTIR spectroscopy show 
changes in the bacteria fingerprint due to treatments. This is distinguished due to the shape of the 
spectra and the various difference in the compounds present in the untreated and treated samples. 
 
4.2.3. Principal Component Analysis  
Principal component analysis (PCA) is a multivariate technique that analyzes data by 
several inter-correlated quantitative dependent variables. It makes it possible to identify 
variances in complex datasets by representing it in a set of new orthogonal variables, which are 
the principal components.  For visualization, each spectrum is plotted as point in a map using 
principal components as x- and y- axes (Abdi & Williams, 2010). PCA reduces the 
dimensionality of large datasets, which increases interpretability and minimizes the information 
loss, solving eigenvector problem [64].   It creates new uncorrelated variables that successively 





Figure 16. Principal Component Analysis for untreated and treated E. coli for Raman scans. (a) Comparison 
of loadings for principal component loadings 1 and 2 (b) Distribution of untreated and treated bacteria with respect 
to Principal Component 1 and 2 
  
  PCA of the Raman datasets of untreated and antibiotic-treated samples determined a   PC 
1 (72%) axis and PC 2 (12%) (Figure 16). The data suggests that the untreated sample had 
significant variations in the regions probed. The treated samples revealed no overlap with the 
untreated samples. The cluster belonging to the two treatments overlapped with each other, 
which suggests that while the samples are different from the untreated that both treatments share 
similarities for a few data points.  
 PCA allows for the difference in the various principal component loadings and their 
corresponding wave numbers to be identified by representing the loadings as a function of 
wavenumber. The data suggest that the main distinction between the PC1 and PC2 here in the 
presence/absence of the bands in the 2700-3300 cm-1 region. These bands are mostly associated 




Figure 17. Principal Component Analysis for untreated and treated E. coli for FTIR scans. 
(a) Comparison of loadings for principal component loadings 1&2 (b) Distribution of untreated 
and treated bacteria with respect to Principal Component 1 and 2 
 
For the PCA analysis of the FTIR spectra (Figure 17), the data points from the three 
sample groups did not clearly separate despite the changes observed when comparing the 
individual spectra. This suggests that additional refinement of the data analysis should be carried 
out to confirm our observations. 





Chapter 5: Conclusion 
 Our study considered nanoscale image and infrared spectroscopy as potential platforms 
capable of differentiating physical and chemical traits in bacteria being inhibiting via different 
modes of action. Our hypothesis was formulated on the premise of several reports in the literature 
indicating that both methods are sensitive the bacterial evolution under various stresses.  
The data gathered indicates that even though significant differences arise upon treatments 
of E. coli, the distinction of the morphological changes with respect to the mode of action of the 
treatment was not straightforward. The simple comparison of length, width and surface roughness 
was not sufficient to clearly establish a distinction that could be used for mode of action 
identification.  
 Raman spectra seemed to provide a better differentiation of the treated cells, although the 
identification of the bands is complex and will require additional work. The present understanding 
of the data would suggest changes in the amide I, II and III bands of the cells. The changes observed 
in the FTIR spectra could not be confirmed with multivariate analysis, which should be considered 
further to pinpoint the origin of this issue.    
 Overall the data tends to agree with our initial hypothesis although a definite identification 
of the changes in bacteria due to a specific mode of action could not be achieved in the scope of 
this study. It is likely that with more work, chemical and physical indicators could serve as an 
establishment for indication of the mode of action of treatments. 
The significance of this work is to be considered in the context of emerging multidrug 
resistance in bacteria. As the developments of new formulations for combating bacterial infections 
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is becoming crucial,  various nanoparticles engineered to provide tailored mode(s) of action and 
targeted delivery are being developed (Yin et al., 2014). For instance, the antibacterial activity of 
zinc oxide (ZnO) NPs has received some interest as an alternative to multidrug resistance for 
several strains of bacteria (Husen & Siddiqi, 2014; Tiwari et al., 2018).  Metal oxides have been 
shown to diffuse into the bacterial cell and release metal ions, leading to cell death. Zn2+ ions can 
attach to the biomolecules in the bacteria cell via electrostatic forces, which further contributes to 
antibacterial activity (Brayner et al., 2006). However, the mode of action of these new compounds 
is difficult to assess. Some studies lean towards membrane disruption as the main effect of ZnO 
NPs on bacteria such as Campylobacter jejuni (Xie, He, Irwin, Jin, & Shi, 2011). Other studies 
have suggested that ZnO NPs may induce intercellular reactive oxygen species (ROS) such as 
hydrogen peroxide, which act as an oxidizing agent to harm the bacterial cells – this would mean 
an ROS mode of action (Jones, Ray, Ranjit, & Manna, 2008). Further research carried out on ZnO-
NP and E. coli shows that ZnO-NPs can adhere to bacterial cell walls. This can lead to the 
bacteria’s outer membrane being ruptured, the intracellular material leaking out, leading to cell 
death (Wahab, Mishra, Yun, Kim, & Shin, 2010). Despite these independent studies, the mode of 
action of ZnO NPs remains unclear. 
The approach considered in this work, if developed further to discriminate the physics and 
chemical traits from bacteria undergoing different treatments, could provide support to accelerate 
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